EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

100366 - Efficacy and safety of dupilumab versus omalizumab in patients with severe chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): Results from a prospective, head-to-head phase 4 trial

Sunday 15 Jun, 16:21 PM - 16:33 PM Glasgow, United Kingdom